title: Reply: To PMID 24591094.
authors.affiliation: Chiba University Graduate School of Medicine.
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Sanayama
authors.forename: Kei
authors.initials: K
authors.lastname: Ikeda
authors.forename: Mieko
authors.initials: M
authors.lastname: Yamagata
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Furuta
authors.forename: Osamu
authors.initials: O
authors.lastname: Ohara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nakajima
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000097:blood*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008297:Male; D008668:Metallothionein / Q000097:blood*; D020411:Oligonucleotide Array Sequence Analysis
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007370:Interferon Type I; D008668:Metallothionein